KEVIN P STARR Insider Trading $EDIT Editas Medicine, Inc.
Get free email notifications about insider trading for KEVIN P STARR.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of KEVIN P STARR. KEVIN P STARR is Director in ALNYLAM PHARMACEUTICALS, INC. ($ALNY) and Director in ZAFGEN, INC. ($ZFGN) and 10% Owner in CytomX Therapeutics, Inc. ($CTMX) and Director in MyoKardia Inc ($MYOK) and 10% Owner in Blueprint Medicines Corp ($BPMC) and in Sage Therapeutics, Inc. ($SAGE) and Director in Sage Therapeutics, Inc. ($SAGE) and 10% Owner in Global Blood Therapeutics, Inc. ($GBT) and Director in Global Blood Therapeutics, Inc. ($GBT) and 10% Owner in Editas Medicine, Inc. ($EDIT).
KEVIN P STARR in Editas Medicine, Inc.
Trading Symbol: EDITIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of KEVIN P STARR: 10% Owner
Holdings: 0 shares
Current Value: $0
Latest Transaction: Sep 07 2016
$EDIT Market Capitalization: $636.78M
$EDIT Previous Close: $18.56
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of KEVIN P STARR in Editas Medicine, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALNY, BPMC, CTMX, EDIT, GBT, LRMR, MYOK, SAGE
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 07 2016 | EDIT | Editas Medicine, I ... | STARR KEVIN P | 10% Owner | Sell | S | 15.90 | 5,890 | 93,666 | 0 | 5.9 K to 0 (-100.00 %) |
Page: 1